| A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout MK Reinders, C Haagsma, TLTA Jansen, EN Van Roon, J Delsing, ... Annals of the Rheumatic Diseases 68 (6), 892-897, 2009 | 254 | 2009 |
| Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized … EC Boerma, M Koopmans, A Konijn, K Kaiferova, AJ Bakker, ... Critical care medicine 38 (1), 93-100, 2010 | 250 | 2010 |
| Clinical relevance of drug-drug interactions: a structured assessment procedure EN van Roon, S Flikweert, M le Comte, PNJ Langendijk, ... Drug safety 28, 1131-1139, 2005 | 237 | 2005 |
| Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol MK Reinders, EN Van Roon, TLTA Jansen, J Delsing, EN Griep, ... Annals of the rheumatic diseases 68 (1), 51-56, 2009 | 204 | 2009 |
| Remission of type 2 diabetes mellitus in patients after different types of bariatric surgery: a population-based cohort study in the United Kingdom JP Yska, EN Van Roon, A De Boer, HGM Leufkens, B Wilffert, ... JAMA surgery 150 (12), 1126-1133, 2015 | 137 | 2015 |
| Safety and efficacy of leflunomide in primary Sjögren’s syndrome: a phase II pilot study JM Van Woerkom, AA Kruize, R Geenen, EN Van Roon, ... Annals of the rheumatic diseases 66 (8), 1026-1032, 2007 | 137 | 2007 |
| Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial JI Van Der Spoel, HM Oudemans-van Straaten, MA Kuiper, EN Van Roon, ... Critical care medicine 35 (12), 2726-2731, 2007 | 132 | 2007 |
| Incidence of discontinuation of highly active antiretroviral combination therapy (HAART) and its determinants EN Van Roon, JM Verzijl, JR Juttmann, AW Lenderink, MJ Blans, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 20 (3), 290-294, 1999 | 123 | 1999 |
| Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients MK Reinders, EN van Roon, PM Houtman, JRBJ Brouwers, TLTA Jansen Clinical rheumatology 26, 1459-1465, 2007 | 117 | 2007 |
| Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma JC de Groot, ENH van Roon, H Storm, NJGM Veeger, AH Zwinderman, ... Journal of Allergy and Clinical Immunology 135 (3), 670-675. e3, 2015 | 112 | 2015 |
| Benzbromarone withdrawn from the European market: Another case of" absence of evidence is evidence of absence"?[1] TLTA Jansen, MK Reinders, EN Van Roon, J Brouwers Clinical and experimental rheumatology 22 (5), 651, 2004 | 100 | 2004 |
| Comorbidity is an independent prognostic factor in patients with advanced‐stage diffuse large B‐cell lymphoma treated with R‐CHOP: a population‐based cohort study A Wieringa, K Boslooper, M Hoogendoorn, P Joosten, T Beerden, ... British journal of haematology 165 (4), 489-496, 2014 | 98 | 2014 |
| Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity EN Van Roon, TLTA Jansen, NM Houtman, P Spoelstra, JRBJ Brouwers Drug safety 27, 345-352, 2004 | 95 | 2004 |
| Cost-benefit analysis of the detection of prescribing errors by hospital pharmacy staff PMLA Van Den Bemt, MJ Postma, EN Van Roon, MCC Chow, R Fijn, ... Drug safety 25, 135-143, 2002 | 90 | 2002 |
| Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes JP Yska, S van der Linde, VV Tapper, JA Apers, M Emous, ER Totté, ... Obesity surgery 23, 819-825, 2013 | 84 | 2013 |
| Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis EN Van Roon, TLTA Jansen, M Van De Laar, M Janssen, JP Yska, ... Annals of the rheumatic diseases 64 (4), 569-574, 2005 | 77 | 2005 |
| Methotrexate bioavailability EN Van Roon, M Van De Laar Clinical and Experimental Rheumatology-Incl Supplements 28 (5), S27, 2010 | 74 | 2010 |
| Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids AL van Ojik, PAF Jansen, JRBJ Brouwers, EN van Roon Drugs & aging 29, 615-625, 2012 | 72 | 2012 |
| Low quality of reporting adverse drug reactions in paediatric randomised controlled trials TW de Vries, EN van Roon Archives of disease in childhood 95 (12), 1023-1026, 2010 | 70 | 2010 |
| Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a … K Boslooper, R Kibbelaar, H Storm, NJGM Veeger, S Hovenga, ... Leukemia & lymphoma 55 (3), 526-532, 2014 | 64 | 2014 |